Literature DB >> 21909123

Macro-management of microRNAs in cell cycle progression of tumor cells and its implications in anti-cancer therapy.

Lin-hui Liang1, Xiang-huo He.   

Abstract

The cell cycle, which is precisely controlled by a number of regulators, including cyclins and cyclin-dependent kinases (CDKs), is crucial for the life cycle of mammals. Cell cycle dysregulation is implicated in many diseases, including cancer. Recently, compelling evidence has been found that microRNAs play important roles in the regulation of cell cycle progression by modulating the expression of cyclins, CDKs and other cell cycle regulators. Herein, the recent findings on the regulation of the cell cycle by microRNAs are summarized, and the potential implications of miRNAs in anti-cancer therapies are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21909123      PMCID: PMC4002725          DOI: 10.1038/aps.2011.103

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  129 in total

1.  Co-delivery of as-miR-21 and 5-FU by poly(amidoamine) dendrimer attenuates human glioma cell growth in vitro.

Authors:  Yu Ren; Chun-Sheng Kang; Xu-Bo Yuan; Xuan Zhou; Peng Xu; Lei Han; Guang Xiu Wang; Zhifan Jia; Yue Zhong; Shizhu Yu; Jing Sheng; Pei-Yu Pu
Journal:  J Biomater Sci Polym Ed       Date:  2010       Impact factor: 3.517

2.  Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia.

Authors:  John A Pulikkan; Viola Dengler; Philomina S Peramangalam; Abdul A Peer Zada; Carsten Müller-Tidow; Stefan K Bohlander; Daniel G Tenen; Gerhard Behre
Journal:  Blood       Date:  2009-12-22       Impact factor: 22.113

3.  MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells.

Authors:  Xiaomei Qin; Xiaohong Wang; Ying Wang; Zhihui Tang; Qinghua Cui; Jianzhong Xi; Yi-Shuan J Li; Shu Chien; Nanping Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-27       Impact factor: 11.205

4.  ATM is down-regulated by N-Myc-regulated microRNA-421.

Authors:  Hailiang Hu; Liutao Du; Gindy Nagabayashi; Robert C Seeger; Richard A Gatti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

5.  Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis.

Authors:  Yutaka Hashimoto; Yoshimitsu Akiyama; Takeshi Otsubo; Shu Shimada; Yasuhito Yuasa
Journal:  Carcinogenesis       Date:  2010-01-15       Impact factor: 4.944

6.  MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2.

Authors:  Niamh H Foley; Isabella M Bray; Amanda Tivnan; Kenneth Bryan; Derek M Murphy; Patrick G Buckley; Jacqueline Ryan; Anne O'Meara; Maureen O'Sullivan; Raymond L Stallings
Journal:  Mol Cancer       Date:  2010-04-21       Impact factor: 27.401

7.  MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2.

Authors:  Qingchuan Dong; Ping Meng; Tao Wang; Weiwei Qin; Weijun Qin; Fuli Wang; Jianlin Yuan; Zhinan Chen; Angang Yang; He Wang
Journal:  PLoS One       Date:  2010-04-14       Impact factor: 3.240

8.  MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation.

Authors:  Lei Shi; Junxia Zhang; Tianhong Pan; Jinfang Zhou; Weiyi Gong; Ning Liu; Zhen Fu; Yongping You
Journal:  Brain Res       Date:  2009-11-27       Impact factor: 3.252

9.  Transcriptional repression of miR-34 family contributes to p63-mediated cell cycle progression in epidermal cells.

Authors:  Dario Antonini; Monia T Russo; Laura De Rosa; Marisa Gorrese; Luigi Del Vecchio; Caterina Missero
Journal:  J Invest Dermatol       Date:  2010-01-21       Impact factor: 8.551

10.  Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer.

Authors:  Wei Shi; Nehad M Alajez; Carlo Bastianutto; Angela B Y Hui; Joseph D Mocanu; Emma Ito; Pierre Busson; Kwok-Wai Lo; Raymond Ng; John Waldron; Brian O'Sullivan; Fei-Fei Liu
Journal:  Int J Cancer       Date:  2010-05-01       Impact factor: 7.396

View more
  11 in total

1.  TGF-beta induced RBL2 expression in renal cancer cells by down-regulating miR-93.

Authors:  J Shi; Y Zhuang; X K Liu; Y X Zhang; Y Zhang
Journal:  Clin Transl Oncol       Date:  2014-09-03       Impact factor: 3.405

Review 2.  MicroRNA aberrations: An emerging field for gallbladder cancer management.

Authors:  Vishal Chandra; Jong Joo Kim; Balraj Mittal; Rajani Rai
Journal:  World J Gastroenterol       Date:  2016-02-07       Impact factor: 5.742

3.  MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway.

Authors:  Zheng-Chao Nie; Wen-Hao Weng; Yu-Shan Shang; Yin Long; Jing Li; Yan-Ting Xu; Zhi Li
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 4.  Friend or foe: the role of microRNA in chemotherapy resistance.

Authors:  Haoran Li; Burton B Yang
Journal:  Acta Pharmacol Sin       Date:  2013-04-29       Impact factor: 6.150

Review 5.  Regulation of multidrug resistance by microRNAs in anti-cancer therapy.

Authors:  Xin An; Cesar Sarmiento; Tao Tan; Hua Zhu
Journal:  Acta Pharm Sin B       Date:  2016-12-03       Impact factor: 11.413

Review 6.  MicroRNA expression and its association with DNA repair in preimplantation embryos.

Authors:  Pinar Tulay; Sioban B Sengupta
Journal:  J Reprod Dev       Date:  2016-02-05       Impact factor: 2.214

Review 7.  Detecting and Characterizing A-To-I microRNA Editing in Cancer.

Authors:  Gioacchino P Marceca; Luisa Tomasello; Rosario Distefano; Mario Acunzo; Carlo M Croce; Giovanni Nigita
Journal:  Cancers (Basel)       Date:  2021-04-03       Impact factor: 6.639

8.  Simultaneously expressed miR-424 and miR-381 synergistically suppress the proliferation and survival of renal cancer cells---Cdc2 activity is up-regulated by targeting WEE1.

Authors:  Binghai Chen; Lujing Duan; Guangming Yin; Jing Tan; Xianzhen Jiang
Journal:  Clinics (Sao Paulo)       Date:  2013-06       Impact factor: 2.365

9.  MicroRNA-217 functions as a tumor suppressor in cervical cancer cells through targeting Rho-associated protein kinase 1.

Authors:  Jing Dong; Maoxiu Wang; Donghua Ni; Lixin Zhang; Wen Wang; Xiujuan Cui; Shijie Fu; Shujuan Yao
Journal:  Oncol Lett       Date:  2018-08-20       Impact factor: 2.967

10.  MiREDiBase, a manually curated database of validated and putative editing events in microRNAs.

Authors:  Gioacchino P Marceca; Rosario Distefano; Carlo M Croce; Giovanni Nigita; Luisa Tomasello; Alessandro Lagana; Francesco Russo; Federica Calore; Giulia Romano; Marina Bagnoli; Pierluigi Gasparini; Alfredo Ferro; Mario Acunzo; Qin Ma
Journal:  Sci Data       Date:  2021-08-04       Impact factor: 8.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.